164 results
8-K
EX-99.1
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
27 Feb 24
Ligand Reports Fourth Quarter and Full Year 2023 Financial Results
7:24am
market acceptance or superiority; Ligand is currently dependent on a single source sole supplier for Captisol and failures by such supplier may result
8-K/A
EX-99.1
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
9 Nov 23
Ligand Reports Third Quarter 2023 Financial Results
9:48pm
on a single source sole supplier for Captisol and failures by such supplier may result in delays or inability to meet the Captisol demands of its partners
8-K
EX-99.1
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
8 Nov 23
Ligand Reports Third Quarter 2023 Financial Results
4:08pm
on a single source sole supplier for Captisol and failures by such supplier may result in delays or inability to meet the Captisol demands of its partners
8-K
EX-10.1
9oyesasm5rj
17 Oct 23
Entry into a Material Definitive Agreement
7:24pm
8-K
EX-99.1
lls 4mg9d0jqmk40onu
8 Aug 23
Ligand Reports Second Quarter 2023 Financial Results
4:02pm
8-K
EX-99.1
m90e0y603u 4orzpvq0
4 May 23
Ligand Reports First Quarter 2023 Financial Results
4:06pm
8-K
EX-99.1
uchu4r7o xkepc2r0
7 Nov 22
Ligand Reports Third Quarter 2022 Financial Results
4:04pm
8-K
EX-99.1
fdnp3mcpfmm1k
8 Aug 22
Ligand Reports Second Quarter 2022 Financial Results
4:06pm
425
fba5vnoi0an3mrndka97
5 May 22
Business combination disclosure
7:30am
8-K
EX-99.1
1067s6
4 May 22
Ligand Reports First Quarter 2022 Financial Results
4:03pm
425
23vdwy
24 Mar 22
Business combination disclosure
9:09am
8-K
EX-2.2
goom crpp
24 Mar 22
Entry into a Material Definitive Agreement
9:08am
8-K
EX-2.1
znxwhfhqm7 bchz
24 Mar 22
Entry into a Material Definitive Agreement
9:08am